Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Actinium Pharmaceuticals starts phase II trial of Actimab-A in patients with AML

Sep. 29, 2016

Beyondspring Pharmaceuticals enrolls first patient in phase Ib/II trial of plinabulin

Sep. 28, 2016

Bristol-Myers Squibb to collaborate with Nectar Therapeutics for cancer combination treatment

Sep. 28, 2016

Hoffmann-La Roche discloses TLR8 agonists

Sep. 28, 2016

Kite Pharma reports topline data from ZUMA-1 study of KTE-C19 in DLBCL

Sep. 28, 2016

FDA places phase III Multikine trial on clinical hold

Sep. 27, 2016

Idera Pharmaceuticals reports initial data from phase I/II trial of IMO-2125

Sep. 27, 2016

Enrollment open in Chugai's phase I trial of ERY-974 for advanced solid tumors

Sep. 26, 2016

Aurigene Discovery Technologies patents PD-1 signaling inhibitors

Sep. 26, 2016

Safety review committee supports continuation of Betalutin trial at higher dose

Sep. 23, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...